DoctorStephen Tristram

Associate Professor and Director of Laboratory Medicine

Health Sciences

  • Associate Professor and Director of Laboratory Medicine
    Health Sciences
  • +61 3 6324 3658 (Fax)
  • +61 3 6324 5469 (Work)
  • School of Health Sciences, Health Sciences, C213 Building C, Newnham Campus, TAS

FUNDED PROJECTS

  • GRANT
    A novel probiotic approach to preventing Haemophilus influenzae biofilms in the respiratory tract
    1 Jun 2024 - 31 Mar 2026
    People funded by this grant:
    • Atto B,
    • Marsh R,
    • Tristram S
    Project Total: $69,600; This application seeks supplementary funding for an existing fellowship-funded project (Exploring a novel approach for preventing otitis media). Infection of the middle ear (otitis media; OM) is an important disease in early childhood- there are ~709 million cases every year, making it one of the most common reasons for health care visits, antibiotic prescription, and preventable hearing loss in children. Children who experience recurrent or persistent episodes of OM are at high risk of developing serious complications, including hearing loss which can have life-long consequences for cognitive and social development. The most common cause of OM is the bacterium Haemophilus influenzae (Hi), which after attaching to the upper airways, migrates to the middle ear where it causes infection. It is difficult to clear this bacterium from the upper airways as it often forms thick aggregates (biofilms) which are highly resistant to antibiotic therapy, resulting in constant or repeat infections. Many children with persistent OM dont respond to current treatments. The goal of this work is to develop a novel therapy, using a non-harmful bacterium (or a protein it produces), that can achieve improved prevention and treatment of OM caused by Hi. Funded by: Clifford Craig Foundation - Grant ($69,600); University of Tasmania.
  • GRANT
    Exploring a novel approach for preventing otitis media
    26 Jun 2023 - 25 Jun 2025
    People funded by this grant:
    • Atto B,
    • Marsh R,
    • Tristram S,
    • Kirkham L-A,
    • Thornton R
    Project Total: $260,556; Infection of the middle ear (otitis media; OM) is an important disease in early childhood- there are ~709 million cases every year, making it one of the most common reasons for health care visits, antibiotic prescription, and preventable hearing loss in children. Children who experience recurrent or persistent episodes of OM are at high risk of developing serious complications, including hearing loss which can have life-long consequences for cognitive and social development. The most common cause of OM is the bacterium Haemophilus influenzae (Hi), which after attaching to the upper airways, migrates to the middle ear where it causes infection. It is difficult to clear this bacterium from the upper airways as it often forms thick aggregates (biofilms) which are highly resistant to antibiotic therapy, resulting in constant or repeat infections. Many children with persistent OM don't respond to current treatments. The goal of this work is to develop a novel therapy, using a non-harmful bacterium (or a protein it produces), that can achieve improved prevention and treatment of OM caused by Hi. Funded by: Garnett Passe and Rodney Williams Memorial Foundation - Junior Fellowship ($260,556); University of Tasmania ($15,573).
  • GRANT
    Exploring a novel approach for preventing otitis media
    1 Mar 2023 - 31 Jan 2025
    People funded by this grant:
    • Atto B,
    • Marsh R,
    • Tristram S,
    • Kirkham L-A,
    • Thornton R
    Project Total: $18,964; This application seeks supplementary funding for an existing fellowship-funded project with the same name (Pass and Williams Junior Fellowship Scheme). Infection of the middle ear (otitis media; OM) is an important disease in early childhood- there are ~709 million cases every year, making it one of the most common reasons for health care visits, antibiotic prescription, and preventable hearing loss in children. Children who experience recurrent or persistent episodes of OM are at high risk of developing serious complications, including hearing loss which can have life-long consequences for cognitive and social development. The most common cause of OM is the bacterium Haemophilus influenzae (Hi), which after attaching to the upper airways, migrates to the middle ear where it causes infection. It is difficult to clear this bacterium from the upper airways as it often forms thick aggregates (biofilms) which are highly resistant to antibiotic therapy, resulting in constant or repeat infections. Many children with persistent OM dont respond to current treatments. The goal of this work is to develop a novel therapy, using a non-harmful bacterium (or a protein it produces), that can achieve improved prevention and treatment of OM caused by Hi. Funded by: Royal National Institute for the Deaf - Grant - Innovation Seed Fund ($18,964); University of Tasmania.
  • GRANT
    Are newly introduced electronic smoking devices safe for smoking cessation and implications for SARS-CoV-2 infection (COVID-19)
    1 Jan 2021 - 31 Dec 2024
    People funded by this grant:
    • Sohal S,
    • Chia C,
    • Larby J,
    • Haug G,
    • Barnsley K
    Project Total: $80,000; The damaging health effects of active and second-hand cigarette smoking are well documented. Tobacco smoke exposure is the primary cause of COPD and lung cancer. However, the prevalence of tobacco smoking is on the gradual decline. In response to this, the tobacco industry is currently changing strategies, shifting the focus from tobacco cigarettes and promoting the safer? alternative in e-cigarettes. e-cigarettes still deliver nicotine and the number of dual users (traditional cigarettes and e-cigarettes) is alarming. We aim to evaluate the effects of e-cigarettes on: 1. Promoting airway inflammation. 2. Airway remodelling changes. 3. Increasing respiratory infections. Funded by: Clifford Craig Foundation - Grant ($80,000); University of Tasmania.
  • GRANT
    Enhancement and further in-vitro validation of a potential probiotic to reduce ear and lung infections caused by Haemophilus influenzae.
    1 Jan 2020 - 31 Jan 2022
    People funded by this grant:
    • Tristram S,
    • Sohal S
    Project Total: $18,150; We have discovered a strain of a harmless bacterial species that lives in the throats of healthy people that produces a novel substance that inhibits the growth of the respiratory pathogen - Haemophilus influenzae. The study involves an evaluation of the potential of this strain as a respiratory probiotic Funded by: Clifford Craig Foundation - Grant ($18,150); University of Tasmania.
  • GRANT
    Potential therapeutic value of normal throat bacteria that produce a novel inhibitory substance for the prevention of respiratory infections
    1 Mar 2018 - 31 Mar 2020
    People funded by this grant:
    • Tristram S,
    • Kunde D,
    • Gell D
    Project Total: $19,000; We have discovered a strain of a harmless bacterial species that lives in the throats of healthy people that produces a novel substance that inhibits the growth of the respiratory pathogen - Haemophilus influenzae. The study involves an evaluation of the potential of this strain as a respiratory probiotic. Funded by: Clifford Craig Foundation - Grant ($19,000); University of Tasmania.
  • GRANT
    Evaluation of an antibiotic-producing bacterial strain to prevent ear infections
    1 Dec 2017 - 1 Dec 2018
    People funded by this grant:
    • Kirkham L-A,
    • Tristram S,
    • Latham R,
    • Lauzon-Joset J,
    • Scott N
    Project Total: $28,863; Will test the ability of a strain of Haemophilus haemolyticus discovered in a previous UTAS project to protect against middle ear type infection with Haemophilus influenzae using a mouse model. Funded by: Wesfarmers Limited - Centre of Vaccines & Infectious Diseases; University of Tasmania.
  • GRANT
    Preliminary development of a probiotic to minimise respiratory infection with Haemophilus influenzae
    1 Jan 2016 - 1 May 2018
    People funded by this grant:
    • Tristram S,
    • Kunde D,
    • Chia C
    Project Total: $17,636; A naturally occurring bacteriocin will be engineered into Haemophilus haemolyticus. As in vitro cell culture model will then be used to evaluate the ability of the bacteriocin producing H. haemolyticus to inhibit colonisation and growth of H. influenzae. Funded by: Clifford Craig Foundation - Grant ($17,636); University of Tasmania.
  • GRANT
    Is Haemophilus haemolyticus a pathogen?
    1 Mar 2015 - 28 Feb 2016
    People funded by this grant:
    • Latham R,
    • Harkness N,
    • Jones D,
    • Tristram S
    Project Total: $10,000; People with respiratory tract diseases have many bacterial species present in their sputum. Haemophilus haemolyticus is frequently present but until now is assumed to be harmless. This project will investigate whether H. haemolyticus is able to cause disease. Funded by: Royal Hobart Hospital Research Foundation - Grant-Starter ($10,000); University of Tasmania.
  • GRANT
    Macrolide resistance in patients with chronic respiratory infections
    1 Jan 2014 - 30 Sep 2015
    People funded by this grant:
    • Tristram S,
    • Kunde D,
    • Haug G,
    • Atkinson C,
    • Chuang A
    Project Total: $15,750; This project will investigate the effect of acquired macrolide resistance genes on survival mechanisms in H. influenzae. It will: a) determine if these genes are expressed (are functional) in this organism; b) determine if these genes increase the fitness of the organism when exposed to sub-lethal concentrations of macrolides; c) determine if the presence of these genes increases the survival of the organism in the intracellular environment of respiratory epithelial cells during exposure to macrolides. It seeks to determine the level of macrolide resistance / prevalence of macrolide resistance genes in identified respiratory pathogens and the general respiratory microbial population in patients with chronic respiratory conditions in Northern Tasmania. The study investigates the longitudinal effect of macrolide therapy on the total respiratory microbial population of selected Northern Tasmanian chronic respiratory patients. Funded by: Clifford Craig Foundation - Grant ($15,750); University of Tasmania.
  • GRANT
    Testing a new therapy against lung infections for people with cystic fibrosis
    1 Jan 2014 - 31 Oct 2015
    People funded by this grant:
    • Roddam L,
    • Cooley M,
    • Ambrose M,
    • Tristram S
    Project Total: $67,782; P. aeruginosa uses small diffusible signal molecules called acyl-homoserine lactones (AHLs) to alter its growth, which enables it to hide from antibiotic therapies and the immune system of the host thereby preventing its eradication from the lungs. These bacterial AHL molecules can also enter and affect human cells leading to further lung damage. This project aims to demonstrate that a novel therapy that inactivates bacterial AHLs can protect human cells from these molecules. Demonstration of this is the first step in showing that this therapy can protect the lungs of people with CF from P. aeruginosa infections. In summary, this new treatment approach should at a minimum prevent a significant amount of the lung damage that occurs, resulting in better quality of life and increased life span. More importantly, this therapy also has the potential to prevent P. aeruginosa lung infections in CF. Funded by: Clifford Craig Foundation - Grant ($67,782); University of Tasmania.
  • GRANT
    Whole genome sequencing of non-typeable H. influenzae to unravel pathogenesis and persistence
    1 Jan 2014 - 31 Dec 2014
    People funded by this grant:
    • Kunde D,
    • Tristram S
    Project Total: $19,000; Non-typeable Haemophilus influenzae (NTHi) is a genetically diverse bacterial commensal of the upper respiratory tract that is also an important opportunistic pathogen when the host is compromised by various disease states. NTHi is a common cause of infectious exacerbations of chronic obstructive pulmonary disease (COPD), community acquired pneumonia, otitis media and sinusitis. It is difficult to estimate the annual burden of disease attributable to NTHi in Australia, however respiratory infections in general are the most common reason for the prescription of antibiotics and accounts for approximately 20 million visits to general practitioners. COPD alone accounts for approximately 10 000 deaths, 55 000 hospitalisations and $400 million in healthcare costs and otitis media is one of the most common reasons for children's GP visits and is associated with temporary hearing impairment and learning deficits. An incomplete understanding of the pathogenesis of infection with NTHi, the absence of a vaccine, increasing antibiotic resistance and the ability to persist in the host despite treatment are all factors which compromise our ability to adequately deal with or reduce the burden of NTHi disease. Funded by: University of Tasmania - Grant-Research Enhancement (REGS); University of Tasmania ($19,000).
  • GRANT
    Are altered penicillin binding proteins in H.influenzae associated with increased capacity to invade respiratory epithelial cells?
    1 Mar 2013 - 19 Dec 2013
    People funded by this grant:
    • Tristram S,
    • Kunde D
    Project Total: $10,000; Funded by: Clifford Craig Foundation - Grant ($10,000); University of Tasmania.
  • GRANT
    Resistance to Macrolide and Fluoroquinolone Antibiotics in Haemophilus Influenzae
    1 Jan 2012 - 27 May 2013
    People funded by this grant:
    • Tristram S
    Project Total: $7,273; Funded by: Clifford Craig Foundation - Grant ($7,273); University of Tasmania.
  • GRANT
    An Amoeba Co-culture Assay Alternative to Mammalian Models of Bacterial Virulence Testing
    8 Aug 2011 - 30 Sep 2013
    People funded by this grant:
    • Champion A,
    • Bradbury R,
    • Tristram S,
    • Latham R
    Project Total: $26,936; Funded by: The MAWA Trust - Grant-Research ($26,936); University of Tasmania.
  • GRANT
    Influence of Specific Prescribing Practices on the Rapid Emergence of Antibiotic Resistance in Haemophilus Influenzae
    1 Jan 2011 - 27 May 2013
    People funded by this grant:
    • Tristram S
    Project Total: $15,636; The aims and objectives of this research are to: create a library of strains of H influenzae identical except for a range of specific single and multiple mutations in the first gene that are associated with emerging antibiotic resistance; perform antibiotic susceptibility tests to determine the relative contribution of specific mutations to levels of resistance; evaluate the performance of E test; design and evaluate real time PCR assays to detect the presence of specific ftsl gene mutations; perform in vitro antibiotic challenge studies to determine which antibiotics and which baseline ftsl gene mutations favour the emergence of specific types of resistant strains. Funded by: Clifford Craig Foundation - Grant ($15,636); University of Tasmania.
  • GRANT
    Development and Evaluation of Laboratory Tests to Detect Important Emerging Antibiotic Resistance in Haemophilus Influenzae
    1 Jan 2009 - 31 May 2010
    People funded by this grant:
    • Tristram S,
    • Dadson P,
    • Nichols S
    Project Total: $8,909; Funded by: Clifford Craig Foundation - Grant ($8,909); University of Tasmania.
  • GRANT
    Development and Evaluation of New Selective Culture Medium for Isolation of Haemophilus Influenzae from Cystic Fibrosis Patients
    1 Jan 2009 - 1 Jan 2010
    People funded by this grant:
    • Tristram S,
    • Reid D
    Project Total: $5,842; Funded by: Clifford Craig Foundation - Grant ($5,842); University of Tasmania.
  • GRANT
    Platypus Partnership - A Community and Science-based Conservation Programme
    30 Aug 2007 - 30 Nov 2009
    People funded by this grant:
    • Geraghty D,
    • Stewart N,
    • Woods G,
    • Tristram S,
    • Forteath N
    Project Total: $50,000; Funded by: Natural Heritage Trust - Grant-Natural Resource Management, Northern Region ($50,000); University of Tasmania.
  • GRANT
    The Acquisition of New Strains of Non-Typeable Haemophilus Influenzae Is The Leading Cause of Acute Exacerbations in Tasmanian COPD Patients
    8 Jan 2007 - 7 Jan 2009
    People funded by this grant:
    • Roddam L,
    • Sanderson K,
    • Wood-Baker R,
    • Tristram S,
    • Haug G
    Project Total: $43,467; Funded by: Clifford Craig Foundation - Grant ($43,467); University of Tasmania.
  • GRANT
    Characterisation of Extended Spectrum B-Lactamases and Cephalosporin Resistance in Clinical Isolates of H. parainfluenzae
    1 Dec 2005 - 1 Dec 2006
    People funded by this grant:
    • Tristram S
    Project Total: $12,500; Funded by: Clifford Craig Foundation - Grant ($12,500); University of Tasmania.
  • GRANT
    Investigation of Antibiotic Sensitivity & Virulence Factors of the Tasmanian Clonal Strain of Pseudomonas aeuruginosa Isolated from Cystic Fibrosis Patients
    31 Oct 2005 - 30 Oct 2006
    People funded by this grant:
    • Roddam L,
    • Reid D,
    • Champion A,
    • Tristram S
    Project Total: $36,000; Funded by: Clifford Craig Foundation - Grant ($36,000); University of Tasmania.
  • GRANT
    Effect of Variant Gene Expression on Antibiotic Resistance in Haemophilus Influenzae and the Implications for Dissemination of Resistance Genes
    1 Jul 2003 - 31 Dec 2004
    People funded by this grant:
    • Tristram S
    Project Total: $2,900; Funded by: Clifford Craig Foundation - Grant ($2,900); University of Tasmania.
  • GRANT
    Genetic Variation in B-Lactamase Genes in Haemophilus Influenzae
    1 Dec 2001 - 31 Dec 2002
    People funded by this grant:
    • Tristram S
    Project Total: $5,000; Funded by: Clifford Craig Foundation - Grant ($5,000); University of Tasmania.
  • GRANT
    Extended Spectrum B-Lactamase in Haemophilus
    1 Jul 2000 - 31 Oct 2001
    People funded by this grant:
    • Tristram S
    Project Total: $4,207; Funded by: Clifford Craig Foundation - Grant ($4,207); University of Tasmania.